Scholarlink

<p>The foreign body reaction often hinders the success of implantable devices, leading to fibrotic encapsulation. Controlling the post-implantation inflammatory phase is key to mitigating the foreign body reaction and promoting device integration. This paper compares three coating strategies for including anti-inflammatory agents onto polyether-ether-ketone (PEEK) surfaces, applying two different zwitterions, namely the 2-methacryloyloxyethyl phosphorylcholine (MPC) and [2-(methacryloyloxy)ethyl]dimethyl-(3-sulfopropyl)ammonium hydroxide (SBMA). Two different PEEK surface types were also compared, namely “rough surface” and “smooth surface” (average roughness: 7&#xa0;μm ± 4&#xa0;μm and 1.4&#xa0;μm ± 0.3&#xa0;μm, respectively). Focused ion beam-scanning electron microscopy (FIB-SEM) confirmed qualitatively the presence of a thin coating layer with an estimated thickness of 100&#xa0;nm. X-ray photoelectron spectroscopy and water contact angle measurements showed that both MPC and SBMA coatings were highly stable on the PEEK substrates for up to 8 weeks in simulated physiological conditions, when anchored to the PEEK surfaces by exploiting zwitterionic copolymers with N-[3-(dimethylamino)propyl]acrylamide and using a polydopamine adhesive layer. These coatings were also tested in vitro, evaluating their effects on cell adhesion, and the production of inflammatory markers such as interleukin-1β, interleukin-6, tumor necrosis factor-α and nitric oxide from M1 macrophages. The MPC-based coating on smooth PEEK surfaces showed the most remarkable effects, significantly supporting macrophage viability, reducing the release of pro-inflammatory cytokines, and inhibiting nitric oxide release, suggesting a superior capability to modulate inflammation. These findings pave the way for functional coatings to be used in vivo, with the aim of improving PEEK implants’ safety, integration, and longevity.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Comparison between SBMA and MPC coatings on PEEK surface: stability over time and anti-inflammatory effects in vitro

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月21日

查看全文
  • Erika Roventini,
  • Francesco Iacoponi,
  • Aliria Poliziani,
  • Paolo Canepa,
  • Ornella Cavalleri,
  • Maria A. Cassa,
  • Paola Parlanti,
  • Carlotta Pucci,
  • Mauro Gemmi,
  • Chiara Tonda-Turo,
  • Leonardo Ricotti

摘要

The foreign body reaction often hinders the success of implantable devices, leading to fibrotic encapsulation. Controlling the post-implantation inflammatory phase is key to mitigating the foreign body reaction and promoting device integration. This paper compares three coating strategies for including anti-inflammatory agents onto polyether-ether-ketone (PEEK) surfaces, applying two different zwitterions, namely the 2-methacryloyloxyethyl phosphorylcholine (MPC) and [2-(methacryloyloxy)ethyl]dimethyl-(3-sulfopropyl)ammonium hydroxide (SBMA). Two different PEEK surface types were also compared, namely “rough surface” and “smooth surface” (average roughness: 7 μm ± 4 μm and 1.4 μm ± 0.3 μm, respectively). Focused ion beam-scanning electron microscopy (FIB-SEM) confirmed qualitatively the presence of a thin coating layer with an estimated thickness of 100 nm. X-ray photoelectron spectroscopy and water contact angle measurements showed that both MPC and SBMA coatings were highly stable on the PEEK substrates for up to 8 weeks in simulated physiological conditions, when anchored to the PEEK surfaces by exploiting zwitterionic copolymers with N-[3-(dimethylamino)propyl]acrylamide and using a polydopamine adhesive layer. These coatings were also tested in vitro, evaluating their effects on cell adhesion, and the production of inflammatory markers such as interleukin-1β, interleukin-6, tumor necrosis factor-α and nitric oxide from M1 macrophages. The MPC-based coating on smooth PEEK surfaces showed the most remarkable effects, significantly supporting macrophage viability, reducing the release of pro-inflammatory cytokines, and inhibiting nitric oxide release, suggesting a superior capability to modulate inflammation. These findings pave the way for functional coatings to be used in vivo, with the aim of improving PEEK implants’ safety, integration, and longevity.